The Valley Desk

NCT03266653 · Interventional trial

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Overall registry status Recruiting

Phase 2

Conditions Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov